{"id":"advm-022","safety":{"commonSideEffects":[{"rate":"null","effect":"Increased intraocular pressure"}]},"_chembl":{"chemblId":"CHEMBL5893587","moleculeType":null,"molecularWeight":"423.52"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By targeting the VEGF-A gene, ADVM-022 aims to reduce the expression of VEGF-A protein, which is involved in the formation of new blood vessels. This approach is intended to treat diseases characterized by abnormal angiogenesis, such as wet age-related macular degeneration.","oneSentence":"ADVM-022 is an adeno-associated virus (AAV) vector-based gene therapy that targets the vascular endothelial growth factor A (VEGF-A) gene.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:19:58.793Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Wet age-related macular degeneration"}]},"trialDetails":[{"nctId":"NCT07482176","phase":"PHASE3","title":"Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)","status":"RECRUITING","sponsor":"Adverum Biotechnologies, Inc.","startDate":"2026-03-16","conditions":"Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD","enrollment":284},{"nctId":"NCT04645212","phase":"","title":"Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]","status":"ACTIVE_NOT_RECRUITING","sponsor":"Adverum Biotechnologies, Inc.","startDate":"2020-12-14","conditions":"Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration","enrollment":23},{"nctId":"NCT06856577","phase":"PHASE3","title":"Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration","status":"RECRUITING","sponsor":"Adverum Biotechnologies, Inc.","startDate":"2025-02-28","conditions":"Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD","enrollment":284},{"nctId":"NCT05536973","phase":"PHASE2","title":"Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]","status":"ACTIVE_NOT_RECRUITING","sponsor":"Adverum Biotechnologies, Inc.","startDate":"2022-08-23","conditions":"Neovascular Age-related Macular Degeneration","enrollment":69},{"nctId":"NCT04418427","phase":"PHASE2","title":"ADVM-022 Intravitreal Gene Therapy for DME","status":"COMPLETED","sponsor":"Adverum Biotechnologies, Inc.","startDate":"2020-05-28","conditions":"Diabetic Macular Edema, Diabetic Retinopathy","enrollment":36},{"nctId":"NCT05607810","phase":"","title":"Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Adverum Biotechnologies, Inc.","startDate":"2022-08-10","conditions":"Diabetic Macular Edema, Diabetic Retinopathy","enrollment":22},{"nctId":"NCT03748784","phase":"PHASE1","title":"ADVM-022 Intravitreal Gene Therapy for Wet AMD","status":"COMPLETED","sponsor":"Adverum Biotechnologies, Inc.","startDate":"2018-11-14","conditions":"Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["AAV.7m8-aflibercept"],"phase":"phase_2","status":"active","brandName":"ADVM-022","genericName":"ADVM-022","companyName":"Adverum Biotechnologies, Inc.","companyId":"adverum-biotechnologies-inc","modality":"Biologic","firstApprovalDate":"","aiSummary":"ADVM-022 is an adeno-associated virus (AAV) vector-based gene therapy that targets the vascular endothelial growth factor A (VEGF-A) gene. Used for Wet age-related macular degeneration.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}